Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2353${count})

  • MJFF Research Grant, 2011
    Multimodal MRI Markers for Parkinson's Disease

    Objective/Rationale: 
    A measurement tool which accurately reflects not only motor deficits but also a host of cognitive dysfunctions seen frequently in Parkinson’s disease (PD) would improve diagnosis...

  • MJFF Research Grant, 2011
    Glyt1 Inhibitors Promote Dopaminergic Striatal Sprouting

    Objective/Rationale:
    An important goal in Parkinson’s disease therapy is to reverse the loss of the dopaminergic neurons of the striatum. We have found that compounds that act as glycine uptake...

  • MJFF Research Grant, 2011
    Ghrelin Concentrations in CSF and Corresponding Serum Samples in PD Patients and Controls

    Objective/Rationale:
    The aim of this study is to establish a valid method for measuring ghrelin concentrations in human cerebrospinal fluid samples. Ghrelin is an appetite-stimulating hormone with...

  • Rapid Response Innovation Awards, 2011
    Psychological Stress as a Risk Factor for Parkinson's Disease

    Objective/Rationale: 
    All persons experience psychological stress. In fact, its pervasiveness is the primary cause of countless diseases. Although the impact of psychological stress on Parkinson’s...

  • Rapid Response Innovation Awards, 2011
    Assessment of AAV Transduction with Wildtype and Constitutively Active p70S6K to Induce Axon Re-Growth in Dopamine Neurons

    Objective/Rationale:
    Available treatments for PD offer relief of symptoms, but none are able to restore the neural structures that have degenerated. Neuroscientists have long believed that surviving...

  • Rapid Response Innovation Awards, 2011
    Xenon Neuroprotection in a Pre-clinical Parkinson's Model

    Objective/Rationale: 
    Xenon is an anesthetic gas known to have an excellent safety profile. Recent research suggests that xenon administered at subanesthetic concentrations is neuroprotective in acute...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.